Dopamine displaces [3H]domperidone from high‐affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: Implications for human positron emission tomography
- 2 June 2003
- Vol. 49 (4) , 209-215
- https://doi.org/10.1002/syn.10232
Abstract
Because the high-affinity state of the dopamine D2 receptor, D2High, is the functional state of the receptor, has a role in demarcating typical from atypical antipsychotics, and is markedly elevated in amphetamine-sensitized rats, it is important to have a method for the convenient detection of this state by a ligand. The present data show that, in contrast to [3H]spiperone or [3H]raclopride, [3H]domperidone labels D2High sites in the presence of isotonic NaCl in either striatum or cloned D2Long receptors, yielding a dopamine dissociation constant (1.75 nM) in agreement with that found with [3H]dopamine. Increased labeling of D2High sites occurred with [3H]domperidone after severe disruption of the cells, suggesting that [3H]domperidone has better access to the D2 receptor from the cytoplasmic aspect of the cell membrane. The density of the [3H]domperidone-labeled D2 receptors was the same as that of the [3H]raclopride-labeled D2 receptors, but twice the density of [3H]spiperone sites for human cloned D2Long receptors, compatible with the monomer-dimer concept of the D2 receptor. [3H]domperidone readily labels the D2High sites in postmortem human brain homogenates. Although [3H]spiperone or [3H]raclopride can occupy D2High sites, the inability of 1–10 nM dopamine to displace these ligands under isotonic conditions suggests that these ligands may not be suitable for monitoring the physiological high-affinity state of the dopamine D2 receptor by means of [11C]methylspiperone or [11C]raclopride in humans. Synapse 49:209–215, 2003.Keywords
This publication has 36 references indexed in Scilit:
- Amphetamine‐sensitized animals show a marked increase in dopamine D2 high receptors occupied by endogenous dopamine, even in the absence of acute challengesSynapse, 2002
- In Vivo Reconstitution of Dopamine D2S Receptor-Mediated G Protein Activation in Baculovirus-Infected Insect Cells: Preferred Coupling to Gi1 versus Gi2Biochemistry, 1996
- Deriving the therapeutic concentrations for clozapine and haloperidol: The apparent dissociation constant of a neuroleptic at the dopamine D2 or D4 receptor varies with the affinity of the competing radioligandEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- [3H]Nemonapride and [3H]Spiperone Label Equivalent Numbers of D2 and D3 Dopamine Receptors in a Range of Tissues and Under Different ConditionsJournal of Neurochemistry, 1995
- The cloned dopamine D2 receptor reveals different densities for dopamine receptor antagonist ligands. Implications for human brain positron emission tomographyEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptorEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- Comparisons between the in Vitro Binding of Two Substituted Benzamides and Two Butyrophenones to Dopamine‐D2 Receptors in the Rat StriatumActa Pharmacologica et Toxicologica, 1986
- Dopamine Receptor Parameters Detected by [3H]Spiperone Depend on Tissue Concentration: Analysis and ExamplesJournal of Neurochemistry, 1984
- Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperoneEuropean Journal of Pharmacology, 1982
- Characterization of 3H-domperidone binding on striatal dopamine receptorsLife Sciences, 1978